Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.

Clinical laboratory

Volumn 54, Issue 9-10, 2008, Pages 389-390

  Shastri, Yogesh M ^a   Povse, Nada ^a   Schröder, Oliver ^a   Stein, Jürgen ^a  

^a Centre of Digestive Diseases and Clinical Nutrition   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; PYRUVATE KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FECES; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRUVATE KINASE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 61449530618     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)